Using our proprietary platform, we partner with companies developing antibodies to provide a custom engineered companion imaging agent with the specificity of the therapeutic antibody and the tailored kinetics of a powerful imaging agent.

We have experience working from any starting point including intact antibody, Fab, scFv, hybridoma, or a newly identified antigen target.   We will determine the best antibody fragment and radiolabeling strategy for your application.

All of our antibody-based imaging agents are fully validated and retain binding similar to the intact antibody.  We have experience working with cell surface and internalizing targets.